MMedication Read More FDA approves GLP-1 weight loss pill Foundayo from Eli LillyApril 1, 2026 The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe…
MMedication Read More New rules will make modern medications easier to access in CzechiaApril 1, 2026 Patients in Czechia will soon find it easier to access modern treatments for chronic conditions as the Ministry…
MMedication Read More Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details | India NewsApril 1, 2026 File photo: ANI NEW DELHI: The Centre has issued a detailed advisory on the use, risks and regulation…
MMedication Read More South Korea’s youngest children see sharpest rise in antidepressant useApril 1, 2026 SEOUL – The number of children and adolescents prescribed antidepressants in South Korea more than doubled in the…
MMedication Read More Central Council For Research In Ayurvedic Sciences, Anuvadini AI Bring Ayurveda Research In 13 LanguagesApril 1, 2026 The Central Council for Research in Ayurvedic Sciences (CCRAS) under Ayush Ministry on Monday signed a memorandum of…
MMedication Read More ‘Allocate key chemicals to avert drug shortages’, says Pharmexcil amid West Asia warApril 1, 2026 New Delhi: The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has urged the government to allocate raw materials…
MMedication Read More NHS head warns UK ‘days away’ from running out of aspirin and paracetamolApril 1, 2026 The NHS lead has said that health bosses are “really worried” as pharmacies across the UK could be…
MMedication Read More Over one million Britons to be handed weight-loss drugs on NHS to prevent heart attacks and strokesApril 1, 2026 More than one million Britons are to be given weight loss drugs on the NHS to prevent against…
MMedication Read More Subscribe to The Australian | Newspaper home delivery, website, iPad, iPhone & Android appsApril 1, 2026 The Australian Digital subscription costs $28 charged monthly for a duration of 12 months, after which it automatically…
MMedication Read More Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEsMarch 31, 2026 Praxis Precision Medicines, Inc. FDA assigned PDUFA target action date of September 27, 2026 BOSTON, March 30, 2026…
MMedication Read More Family elated drug for daughter fundedMarch 31, 2026 A Dunedin family say they are over the moon that a potentially ‘‘life-saving’’ drug treating cystic fibrosis (CF)…
MMedication Read More Carroll MacNeill confirms free blisters packs to continue for vulnerableMarch 31, 2026 The Government has said that patients who previously received blister packs free of charge will continue to do…